Uracil Mustard

乌拉莫司丁

Report date: 2022/03/23 14:30:19

Base Information

Drug NameUracil Mustard
Drug Alias Name尿嘧啶芥尿嘧啶氮芥Uracil Mustard
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsLymphoma, Non-HodgkinLeukemia, Myelogenous, ChronicLeukemia, Lymphocytic, Chronic, B-Cell
Global Approved IndicationsLymphoma, Non-HodgkinLeukemia, Myelogenous, ChronicLeukemia, Lymphocytic, Chronic, B-Cell
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1962/09/13
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesShire Development Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesShire Development Llc
Active IndicationsN/A
Inactive IndicationsLymphoma, Non-HodgkinLeukemia, Myelogenous, ChronicLeukemia, Lymphocytic, Chronic, B-Cell

Other Information

ATC CodeL01AD08
Related LinksWikipediaDrugBankKEGG